Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.
作者信息
Paltiel A David, Zheng Amy, Schwartz Jason L
机构信息
Yale School of Public Health, New Haven, Connecticut.
Harvard Medical School, Boston, Massachusetts.
出版信息
Ann Intern Med. 2021 Apr;174(4):568-570. doi: 10.7326/M20-7866. Epub 2021 Jan 5.
Abstract
摘要
相似文献
1
Speed Versus Efficacy: Quantifying Potential Tradeoffs in COVID-19 Vaccine Deployment.速度与效果：量化新冠疫苗部署中的潜在权衡
Ann Intern Med. 2021 Apr;174(4):568-570. doi: 10.7326/M20-7866. Epub 2021 Jan 5.
2
COVID-19 Vaccine: Practical Clinical Considerations.新型冠状病毒肺炎疫苗：实用临床注意事项。
Ann Intern Med. 2021 May;174(5):694. doi: 10.7326/M21-1260. Epub 2021 Mar 26.
3
A Public Health COVID-19 Vaccination Strategy to Maximize the Health Gains for Every Single Vaccine Dose.最大化每剂疫苗健康收益的公共卫生 COVID-19 疫苗接种策略。
Ann Intern Med. 2021 Apr;174(4):552-553. doi: 10.7326/M20-8060. Epub 2021 Jan 5.
4
Moving Forward Together.携手共进。
Am J Nurs. 2021 Jun 1;121(6):7. doi: 10.1097/01.NAJ.0000753572.44300.be.
5
Risk Compensation and COVID-19 Vaccines.风险补偿与 COVID-19 疫苗。
Ann Intern Med. 2021 Jun;174(6):858-859. doi: 10.7326/M20-8251. Epub 2021 Mar 2.
6
SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn.SARS-CoV-2 疫苗：成就斐然，仍有许多需要学习。
Ann Intern Med. 2021 May;174(5):687-690. doi: 10.7326/M21-0111. Epub 2021 Jan 19.
7
Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic.新冠疫情期间评估新冠病毒疫苗的挑战。
CMAJ. 2020 Aug 24;192(34):E982-E985. doi: 10.1503/cmaj.201237. Epub 2020 Jul 9.
8
When culture, traditions and public health clash: A paradigm shift urgently needed to stem the spread of COVID-19 in Zimbabwe.当文化、传统与公共卫生发生冲突时：津巴布韦迫切需要范式转变以遏制新冠病毒的传播。
S Afr Med J. 2021 Mar 5;111(4):13235. doi: 10.7196/SAMJ.2021.v111i4.15637.
9
Weathering COVID-19 storm: Successful control measures of five Asian countries.应对新冠疫情风暴：五个亚洲国家成功的防控措施。
Am J Infect Control. 2020 Jul;48(7):851-852. doi: 10.1016/j.ajic.2020.04.021. Epub 2020 Apr 29.
10
Alternative Dose Allocation Strategies to Increase Benefits From Constrained COVID-19 Vaccine Supply.增加有限新冠疫苗供应效益的替代剂量分配策略
Ann Intern Med. 2021 Apr;174(4):570-572. doi: 10.7326/M20-8137. Epub 2021 Jan 5.
引用本文的文献
1
2
Physical activities pre- and post-COVID-19 vaccination and its implementations: A narrative review.新冠病毒疫苗接种前后的体育活动及其实施：一项叙述性综述。
SAGE Open Med. 2023 Mar 6;11:20503121231158981. doi: 10.1177/20503121231158981. eCollection 2023.
3
An extended SARS-CoV-2 mRNA vaccine prime-boost interval enhances B cell immunity with limited impact on T cells.延长的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）信使核糖核酸（mRNA）疫苗初免-加强间隔可增强B细胞免疫，对T细胞的影响有限。
iScience. 2023 Jan 20;26(1):105904. doi: 10.1016/j.isci.2022.105904. Epub 2022 Dec 29.
4
Hospitalization among vaccines for SARS-CoV-2 breakthrough infection after dose sparing strategies in Libya: A cohort study.利比亚采用剂量节省策略后，SARS-CoV-2 突破感染疫苗的住院情况：一项队列研究。
PLoS One. 2022 Nov 3;17(11):e0276425. doi: 10.1371/journal.pone.0276425. eCollection 2022.
5
Managing two-dose COVID-19 vaccine rollouts with limited supply: Operations strategies for distributing time-sensitive resources.在供应有限的情况下管理两剂次新冠疫苗接种：分配时间敏感型资源的运营策略
Prod Oper Manag. 2022 Oct 7. doi: 10.1111/poms.13862.
6
Vaccination strategies when vaccines are scarce: on conflicts between reducing the burden and avoiding the evolution of escape mutants.疫苗短缺时的疫苗接种策略：减少负担与避免逃逸突变体进化之间的冲突。
J R Soc Interface. 2022 Jun;19(191):20220045. doi: 10.1098/rsif.2022.0045. Epub 2022 Jun 29.
7
Temporal associations of B and T cell immunity with robust vaccine responsiveness in a 16-week interval BNT162b2 regimen.在 16 周 BNT162b2 方案中，B 细胞和 T 细胞免疫与强大疫苗反应之间的时间关联。
Cell Rep. 2022 Jun 28;39(13):111013. doi: 10.1016/j.celrep.2022.111013. Epub 2022 Jun 13.
8
Efficacy versus abundancy: Comparing vaccination schemes.功效与数量：比较疫苗接种方案。
PLoS One. 2022 May 12;17(5):e0267840. doi: 10.1371/journal.pone.0267840. eCollection 2022.
9
Importance of vaccine action and availability and epidemic severity for delaying the second vaccine dose.疫苗作用和供应情况以及疫情严重程度对推迟第二剂疫苗接种时间的重要性。
Sci Rep. 2022 May 10;12(1):7638. doi: 10.1038/s41598-022-11250-4.
10
The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants.在变异情况下，权衡 COVID-19 疫苗的分配速度与不同疗效水平的平衡作用。
Sci Rep. 2022 May 6;12(1):7493. doi: 10.1038/s41598-022-11060-8.
Zotero 插件